MPLT

Maplight Therapeutics Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 0/10
  • Momentum↓ 0/10
Maplight Therapeutics sales and earnings growth
MPLT Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ 0.00%
  • FCF Y/Y↓ 0.00%
Maplight Therapeutics gross and profit margin trends
MPLT Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ 0.00%
Maplight Therapeutics net debt vs free cash flow
MPLT Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ 0.0

Maplight Therapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗